Willingness to pay vs lottery equivalent to value the impact of alcohol misuse on quality of life

References

• Gonçalves R, Lourenço A, Da Silva SN. A social cost perspective in the wake of the Portuguese strategy for the fight against drugs. Int J Drug Policy. 2015;26(2):199–209.
   PubMed Web of Science ®Google Scholar
• Lievens D, Vander Laenen F, Verhaeghe N, et al. Economic consequences of legal and illegal drugs: the case of social costs in Belgium. Int J Drug Policy. 2017;44:50–57.
   PubMed Web of Science ®Google Scholar
• Verhaeghe N, Lievens D, Annemans L, et al. Methodological considerations in social cost studies of addictive substances: a systematic literature review. Front Public Health. 2017;4:295.
   PubMed Web of Science ®Google Scholar
• Barrio P, Reynolds J, García-Altés A, et al. Social costs of illegal drugs, alcohol and tobacco in the European Union: a systematic review. Drug Alcohol Rev. 2017;36(5):578–588.
   PubMed Web of Science ®Google Scholar
• Anderson P, Baumberg B. Alcohol in Europe. London: Institute of Alcohol Studies. A public health perspective; 2006.
   Google Scholar
• Collins D, Lapsley H (2008). The avoidable costs of alcohol abuse in Australia and the potential benefits of effective policies to reduce the social costs of alcohol. Department of health and ageing (Australian Government).
   Google Scholar
• Jarl J, Johansson P, Eriksson A, et al. The societal cost of alcohol consumption: an estimation of the economic and human cost including health effects in Sweden, 2002. Eur J Health Econ. 2008;9(4):351–360.
   PubMed Web of Science ®Google Scholar
• Drummond MF, Sculpher MJ, and Claxton K, et al. Methods for the economic evaluation of health care programmes. Oxford: Oxford university press; 2015.
   Google Scholar
• Tarricone R. Cost-of-illness analysis: what room in health economics? Health Policy. 2006;77(1):51–63.
   PubMed Web of Science ®Google Scholar
• Hammitt JK. QALYs versus WTP. Risk Anal. 2002;22(5):985–1001.
   PubMed Web of Science ®Google Scholar
• Oliver A. Testing the internal consistency of the lottery equivalents method using health outcomes. Health Econ. 2005;14(2):149–159.
   PubMed Web of Science ®Google Scholar
• Bleichrodt H, Abellan-Perpiñan JM, Pinto-Prades JL, et al. Resolving inconsistencies in utility measurement under risk: tests of generalizations of expected utility. Manage Sci. 2007;53(3):469–482.
   Web of Science ®Google Scholar
• Abellán Perpiñán JM, Sanchez Martinez FI, Martínez Pérez JE, et al. Lowering the ‘floor’ of the SF‐6D scoring algorithm using a lottery equivalent method. Health Econ. 2012;21(11):1271–1285.
   PubMed Web of Science ®Google Scholar
• McCord M, de Neufville R. Lottery equivalents: reduction of the certainty effect problem in utility assessment. Manage Sci. 1986;32(1):56–60.
   Web of Science ®Google Scholar
• Green MC, Brazier J, Deverill M. Valuing health-related quality of life. Pharmacoeconomics. 2000;17(2):151–165.
   PubMed Web of Science ®Google Scholar
• Tsuchiya A, Brazier J, Roberts J. Comparison of valuation methods used to generate the EQ-5D and the SF-6D value sets. J Health Econ. 2006;25(2):334–346.
   PubMed Web of Science ®Google Scholar
• Nimdet K, Chaiyakunapruk N, Vichansavakul K, et al. A systematic review of studies eliciting willingness-to-pay per quality-adjusted life year: does it justify CE threshold? PloS One. 2015;10(4):e0122760.
   PubMed Web of Science ®Google Scholar
• Ryen L, Svensson M. The willingness to pay for a quality adjusted life year: a review of the empirical literature. Health Econ. 2015;24(10):1289–1301.
   PubMed Web of Science ®Google Scholar
• Vallejo-Torres L, García-Lorenzo B, Rivero-Arias O, et al. The societal monetary value of a QALY associated with EQ-5D-3L health gains. Eur J Health Econ. 2020;21(3):363–379.
   PubMed Web of Science ®Google Scholar
• Jeanrenaud C, Pellegrini S. Valuing intangible costs of alcohol dependence: a contingent valuation study. Revue d’économie politique. 2007;117(5):813–825.
   Web of Science ®Google Scholar
• Petrie D, Doran C, Shakeshaft A. Willingness to pay to reduce alcohol-related harm in Australian rural communities. Expert Rev Pharmacoecon Outcomes Res. 2011;11(3):351–363.
   PubMed Web of Science ®Google Scholar
• Mosquera Nogueira J, Rodríguez-Míguez E. Intangible costs of alcohol dependence from the perspective of patients and their relatives: a contingent valuation study. Adicciones. 2018;30(2):111–122.
   PubMed Web of Science ®Google Scholar
• Stouthard ME, Essink-Bot ML, Bonsel GJ, DUTCH DISABILITY WEIGHTS (DDW) GROUP. Disability weights for diseases: a modified protocol and results for a Western European region. Eur J Public Health. 2000;10(1):24–30.
   Web of Science ®Google Scholar
• Sanderson K, Andrews G, Corry J, et al. Using the effect size to model change in preference values from descriptive health status. Qual Life Res. 2004;13(7):1255–1264.
   PubMed Web of Science ®Google Scholar
• Kraemer KL, Roberts MS, Horton NJ, et al. Health utility ratings for a spectrum of alcohol-related health states. Med Care. 2005;43(6):541–550.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Míguez E, Mosquera Nogueira J. Measuring the impact of alcohol-related disorders on quality of life through general population preferences. Gac Sanit. 2017;31(2):89–94.
   PubMed Web of Science ®Google Scholar
• Saarni SI, Suvisaari J, Sintonen H, et al. Impact of psychiatric disorders on health-related quality of life: general population survey. Br J Psychiatry. 2007;190(4):326–332.
   PubMedGoogle Scholar
• Petrie D, Doran C, Shakeshaft A, et al. The relationship between alcohol consumption and self-reported health status using the EQ5D: evidence from rural Australia. Soc Sci Med. 2008;67(11):1717–1726.
   PubMed Web of Science ®Google Scholar
• Maheswaran H, Petrou S, Rees K, et al. Estimating EQ-5D utility values for major health behavioural risk factors in England. J Epidemiol Community Health. 2013;67(2):172–180.
   PubMed Web of Science ®Google Scholar
• Mosquera Nogueira J, Rodríguez-Míguez E. Using the SF-6D to measure the impact of alcohol dependence on health-related quality of life. Eur J Health Econ. 2015;16(4):347–356.
   PubMed Web of Science ®Google Scholar
• Günther OH, Roick C, Angermeyer MC, et al. Responsiveness of EQ-5D utility indices in alcohol-dependent patients. Drug Alcohol Depend. 2008;92(1–3):291–295.
   PubMed Web of Science ®Google Scholar
• Luquiens A, Reynaud M, Falissard B, et al. Quality of life among alcohol-dependent patients: how satisfactory are the available instruments? A systematic review. Drug Alcohol Depend. 2012;125(3):192–202.
   PubMed Web of Science ®Google Scholar
• Essex HN, White IR, Khadjesari Z, et al. Quality of life among hazardous and harmful drinkers: EQ-5D over a 1-year follow-up period. Qual Life Res. 2014;23(2):733–743.
   PubMed Web of Science ®Google Scholar
• Payakachat N, Ali MM, Tilford JM. Can the EQ-5D detect meaningful change? A systematic review. Pharmacoeconomics. 2015;33(11):1137–1154.
   PubMed Web of Science ®Google Scholar
• Chavez LJ, Bradley K, Tefft N, et al. Preference weights for the spectrum of alcohol use in the US population. Drug Alcohol Depend. 2016;161:206–213.
   PubMed Web of Science ®Google Scholar
• Casal B, Rodríguez-Míguez E, and Rivera B. Measuring intangible cost-of-morbidity due to substance dependence: implications of using alternative preference-based instruments. Eur J Health Econ. 2020;21:1039–1048.
   PubMed Web of Science ®Google Scholar
• Møller L, Matic S, & World Health Organization. (2010). Best practice in estimating the costs of alcohol: recommendations for future studies.
   Google Scholar
• Bobinac A, van Exel NJA, Rutten FF, et al. GET MORE, PAY MORE? An elaborate test of construct validity of willingness to pay per QALY estimates obtained through contingent valuation. J Health Econ. 2012;31(1):158–168.
   PubMed Web of Science ®Google Scholar
• Mosquera J, and Rodríguez-Míguez E. Intangible costs of alcohol dependence from the perspective of patients and their relatives: a contingent valuation study. Adicciones. 2018;30(2):111–121.
   PubMed Web of Science ®Google Scholar
• Blomquist GC, Blumenschein K, Johannesson M. Eliciting willingness to pay without bias using follow-up certainty statements: comparisons between probably/definitely and a 10-point certainty scale. Environmental and Resource Economics. 2009;43(4):473–502.
   Web of Science ®Google Scholar
• Rosko MD, DeVita M, McKenna WF, et al. Strategic marketing applications of conjoint analysis: an HMO perspective. Journal of Health Care Marketing. 1985. 5(4).
   PubMedGoogle Scholar
• Gonzalez JM. A guide to measuring and interpreting attribute importance. Patient-Patient-Centered Outcomes Res. 2019;12(3):287–295.
   Web of Science ®Google Scholar
• Polsky D, Glick HA, Willke R, et al. Confidence intervals for cost–effectiveness ratios: a comparison of four methods. Health Econ. 1997;6(3):243–252.
   PubMed Web of Science ®Google Scholar
• O’Brien B, Viramontes JL. Willingness to pay: a valid and reliable measure of health state preference? Med Decis Mak. 1994;14(3):289–297.
   PubMed Web of Science ®Google Scholar
• Pinto-Prades JL, Loomes G, Brey R. Trying to estimate a monetary value for the QALY. J Health Econ. 2009;28(3):553–562.
   PubMed Web of Science ®Google Scholar
• Smith RD. The relative sensitivity of willingness‐to‐pay and time‐trade‐off to changes in health status: an empirical investigation. Health Econ. 2001;10(6):487–497.
   PubMed Web of Science ®Google Scholar
• Bala MV, Wood LL, Zarkin GA, et al. Valuing outcomes in health care: a comparison of willingness to pay and quality-adjusted life-years. J Clin Epidemiol. 1998;51(8):667–676.
   PubMed Web of Science ®Google Scholar
• Robinson A, Gyrd-Hansen D, Bacon P, et al. Estimating a WTP-based value of a QALY: the ‘chained’approach. Soc Sci Med. 2013;92:92–104.
   PubMed Web of Science ®Google Scholar
• Martín-Fernández J, Polentinos-Castro E, Del Cura-gonzález MI, et al. Willingness to pay for a quality-adjusted life year: an evaluation of attitudes towards risk and preferences. BMC Health Serv Res. 2014;14(1):287.
   PubMedGoogle Scholar
• Van Houtven G, Powers J, Jessup A, et al. Valuing avoided morbidity using meta‐regression analysis: what can health status measures and QALYs tell us about WTP? Health Econ. 2006;15(8):775–795.
   PubMed Web of Science ®Google Scholar
• Hammitt JK, Haninger K. Willingness to pay for food safety: sensitivity to duration and severity of illness. Am J Agric Econ. 2007;89(5):1170–1175.
   Web of Science ®Google Scholar
• Haninger K, Hammitt JK. Diminishing willingness to pay per Quality‐Adjusted life year: valuing acute foodborne illness. Risk Analysis: An International Journal. 2011;31(9):1363–1380.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Míguez E, Pinto-Prades JL, Mosquera-Nogueira J. Eliciting health state utilities using paired-gamble methods: the role of the starting point. Value Health. 2019;22(4):446–452.
   PubMed Web of Science ®Google Scholar
• Soeteman L, van Exel J, Bobinac A. The impact of the design of payment scales on the willingness to pay for health gains. Eur J Health Econ. 2017;18(6):743–760.
   PubMed Web of Science ®Google Scholar
• Goldberg I, Roosen J. Scope insensitivity in health risk reduction studies: a comparison of choice experiments and the contingent valuation method for valuing safer food. Journal of Risk and Uncertainty. 2007;34(2):123–144.
   Web of Science ®Google Scholar
• Kanya L, Sanghera S, Lewin A, et al. The criterion validity of willingness to pay methods: a systematic review and meta-analysis of the evidence. Soc Sci Med. 2019;232:238–261.
   PubMed Web of Science ®Google Scholar
• Blumenschein K, Blomquist GC, Johannesson M, et al. Eliciting willingness to pay without bias: evidence from a field experiment. Econ J. 2008;118(525):114–137.
   Web of Science ®Google Scholar
• Picci RL, Oliva F, Zuffranieri M, et al. Quality of life, alcohol detoxification and relapse: is quality of life a predictor of relapse or only a secondary outcome measure? Qual Life Res. 2014;23(10):2757–2767.
   PubMed Web of Science ®Google Scholar
• Gyrd-Hansen D. Willingness to pay for a QALY. Pharmacoeconomics. 2005;23(5):423–432.
   PubMed Web of Science ®Google Scholar
• Nice. Appraising life-extending, end of life treatments. London(UK): National Institute for Health and Clinical Excellence; 2009.
   Google Scholar
• Gu Y, Lancsar E, Ghijben P, et al. Attributes and weights in health care priority setting: a systematic review of what counts and to what extent. Soc Sci Med. 2015;146:41–52.
   PubMed Web of Science ®Google Scholar
• Nord E, Johansen R. Concerns for severity in priority setting in health care: a review of trade-off data in preference studies and implications for societal willingness to pay for a QALY. Health Policy. 2014;116(2–3):281–288.
   PubMed Web of Science ®Google Scholar
• Lancsar E, Gu Y, Gyrd-Hansen D, et al. The relative value of different QALY types. J Health Econ. 2020;70:102303.
   PubMed Web of Science ®Google Scholar